InsidersTradesSigma
Follow the Tiziana Life Sciences Ltd share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €166.7m. The latest transaction was filed on 17 June 2026 (Attribution). Among the most active insiders: CERRONE GABRIELE M. The full history is accessible without an account.
Analysts rate Tiziana Life Sciences Ltd Strong Buy (bullish), based on 1 analysts. Average price target: US$9.09.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Tiziana Life Sciences Ltd is a biopharmaceutical company focused on developing innovative treatments for serious diseases. It is listed on NASDAQ under the ticker TLSA.